The mechanism (s) for thrombosis and pregnancy losses in the anti-phospholipid antibody
syndrome have not yet been established. Annexin-V is an anionic phospholipid-binding …

Atherosclerosis, a major cause of disease and death from cardiovascular disease (CVD), is
an inflammatory disease characterized by T cell and monocyte/macrophage infiltration in the …

Antiphospholipid (aPL) antibodies recognize receptor-bound β2 glycoprotein I (β2GPI) on
target cells, and induce an intracellular signaling and a procoagulant/proinflammatory …

The paradoxical correlation between thrombosis and the lupus anticoagulant (LAC) effect is
an enigmatic feature of the antiphospholipid (aPL) syndrome. The Dutch authors previously …

The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the
clinical features of recurrent thrombosis in the venous or arterial circulation and fetal losses …

This study investigated the prevalence of antibody against annexin II (A2) in patients with
antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE). It also explored …

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by arterial,
venous or small-vessel thrombotic events, and recurrent miscarriages or fetal loss. APS …

Antiphospholipid syndrome (APS) is defined by clinical manifestations that include
thrombosis and/or fetal loss or pregnancy morbidity in patients with antiphospholipid …

The antiphospholipid syndrome is a thrombophilic condition marked by antibodies that
recognize anionic phospholipid-protein cofactor complexes. We recently reported that …

Antiphospholipid antibodies (aPL), the majority of which are directed against β2-
glycoprotein I (β2GPI), are associated with an increased incidence of venous and arterial …